Moreover, knockdown of G3BP2 effectively suppressed EPS8L2-mediated tumor growth in vivo, suggesting that G3BP2 is a critical downstream effector of EPS8L2 in cancer progression. The gene discussed is G3BP2; the disease is neoplasm.